HOME >> MEDICINE >> NEWS
Novel 'delivery' method for nutrients wins Kaye Innovation Award for Hebrew university students

Increasingly, the public wants to "eat healthy," consuming foods that are high in the nutrients that are considered beneficial. The problem is that many of these food components are ultimately ineffective.

This is so because most bioactive phytochemicals (chemical components derived from plants) are not soluble in water, and therefore their absorption via the digestive system is very limited. In plain terms, the beneficial components simply pass through our bodies.

In order to solve this problem, two Ph.D. students at the Hebrew University of Jerusalem have contributed to the development of "nanovehicles" that can successfully transport the desired components through the digestive system. For their successful work, the two students, Aviram Spernath and Idit Yuli-Amar are first-prize student winners of this year's Kaye Innovation Awards at the Hebrew University, which were presented on June 8 during the 67th meeting of the university's Board of Governors.

Spernath and Yuli-Amar have been working under the supervision of Prof. Nissim Garti and Dr. Abraham Aserin at the Hebrew University's Casali Institute of Applied Chemistry in developing nanodroplets and tiny liquid crystals that are effective in binding with, dissolving, stabilizing and retaining food or medicinal chemicals, thereby creating microemulsions. The vehicles are built using complex formulations involving emulsifiers, water, oil and alcohol.

These nanodroplets or liquid-crystals, each bearing the desired bioactive chemicals, can be incorporated into liquid or solid food, capsules, powders or tablets. The vehicles' retentive qualities and nanostructure enable them to be successfully absorbed through digestive membranes. The method has significant health implications for both better nutrition and medical treatment.

Spernath, 35, who lives in Kfar Saba, and Yuli-Amar, 28, of Jerusalem stress that their specially
'"/>

Contact: Jerry Barach
jerryb@savion.huji.ac.il
972-2-5882904
The Hebrew University of Jerusalem
9-Jun-2004


Page: 1 2

Related medicine news :

1. Novel therapy tested in mice could chase away cat allergies
2. Novel antibiotic shows promise in shortening treatment duration of tuberculosis
3. Novel p53 gene-based therapy boosts immune system and reduces tumor size
4. Novel drugs help solve Gleevec resistance
5. Novel imaging technique shows abnormal brain anatomy in children with ADHD
6. Novel drug-antidote strategy provides greater control of drug action
7. Novel imaging technique shows lymph nodes, metastases in breast cancer without surgery
8. Novel vitamin discovery offers clues for cancer chemotherapy and lipid disorders
9. Novel findings about neovessel formation
10. Novel MRI technique provides clear images of blood flow
11. Novelty-seeking teens may be more easily influenced by tobacco advertisements

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... 2017 , ... “America On The Brink”: the Christian history of the United ... the creation of published author, William Nowers. Captain Nowers and his wife, Millie, ... spent thirty years in the Navy. Following his career as a naval aviator ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
(Date:10/12/2017)... ... , ... The American College of Medical Informatics (ACMI) will present the 2017 ... Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is ... pioneer in the field of medical informatics, this prestigious award is presented to an ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... 2017 AVACEN Medical , Inc. (AVACEN) announced ... 2017 New Product Innovation Award for Its fibromyalgia pain ... secondary medical device market research by Frost & Sullivan,s industry ... drug-free pain relief product, the AVACEN 100, offers a safe ... widespread pain. ...
(Date:10/12/2017)... 12, 2017 West Pharmaceutical Services, Inc. ... for injectable drug administration, today announced that it will ... on Thursday, October 26, 2017, and will follow with ... expectations at 9:00 a.m. Eastern Time. To participate on ... The conference ID is 94093362. ...
(Date:10/11/2017)... 2017  Caris Life Sciences ® , a leading ... of precision medicine, today announced that St. Jude Medical ... Alliance™ (POA) as its 17 th member. Through ... Crosson Cancer Institute will help develop standards of care ... profiling, making cancer treatment more precise and effective. ...
Breaking Medicine Technology:
Cached News: